Pharmajobs

• Index measures pharma CSR activity
  
  10 Mar 2010
  The 2010 Access to Medicine Index, the only Index to rank the efforts of pharmaceutical companies in providing global access to medicine, is to be published this June in Amsterdam. Read More
  
  

  Back to Top

• Transgene and Novartis to co-develop cancer treatment
  
  10 Mar 2010
  Transgene has signed an exclusive agreement with Novartis for the development and commercialisation of a new targeted immunotherapy product for non-small cell lung cancer (NSCLC) and other potential cancer indications. Read More
  
  

  Back to Top

• Pfizer and King’s College collaborate on pain research
  
  09 Mar 2010
  Pfizer has partnered with King’s College London to create an open innovation laboratory for pain research. Read More
  
  

  Back to Top

• Warwick team to review new treatments
  
  09 Mar 2010
  A new team at the University of Warwick has been awarded £2.6 million to conduct Technology Assessment Reviews (TARs) on new treatments. Read More
  
  

  Back to Top

• Government invests in cancer awareness campaigns
  
  09 Mar 2010
  The Government has pledged £8 million to help local NHS organisations fund campaigns that improve early diagnosis of cancer. Read More
  
  

  Back to Top

• Datamonitor predicts decline in CVD profits
  
  08 Mar 2010
  Pharmaceutical companies will struggle to profit from the cardiovascular disease (CVD) market over the next decade despite growing drug usage, says Datamonitor. Read More
  
  

  Back to Top

• EUSA Pharma secures European position
  
  08 Mar 2010
  EUSA Pharma has completed the build of its executive management team and commercial infrastructure with the appointment of Iain McGill to the role of President, Europe and International. Read More
  
  

  Back to Top

• Allergan and BMS collaborate on pain treatment
  
  08 Mar 2010
  Bristol-Myers Squibb and Allergan have signed a global agreement for a neuropathic pain treatment candidate currently under Phase II development by Allergan. Read More
  
  

  Back to Top

• Best companies success for Napp Pharmaceuticals
  
  05 Mar 2010
  Napp Pharmaceuticals has achieved fifth position in the Sunday Times Top 100 Best Mid-sized Companies to Work For list and remains the highest ranked pharmaceutical company in the UK. Read More
  
  

  Back to Top

• Boost for Intercell vaccine in the UK
  
  05 Mar 2010
  The Joint Committee on Vaccination and Immunization (JCVI) in the UK has recommended the use of Intercell’s Ixiaro to protect people at high risk of contracting Japanese Encephalitis. Read More
  
  

  Back to Top

• BMS reveals new CEO
  
  05 Mar 2010
  Bristol-Myers Squibb has announced that Lamberto Andreotti will take over as the company’s Chief Executive Officer when current Chairman and CEO James M. Cornelius retires. Read More
  
  

  Back to Top

• NICE restricts RA treatment options
  
  04 Mar 2010
  This week, NICE has published three recommendations that could “drastically limit” the treatment options available to patients with severe rheumatoid arthritis (RA). Read More
  
  

  Back to Top

• Forbes reveals the world’s most expensive drugs
  
  04 Mar 2010
  Specialty drugs for rare diseases have been shown to be the most costly, according to market and analysts’ data gathered by Forbes magazine. Read More
  
  

  Back to Top

• Celgene to appeal Vidaza decision
  
  04 Mar 2010
  Celgene UK will appeal NICE’s decision against the use of Vidaza (azacitidine) in patients with higher-risk myelodysplastic syndrome (MDS), a rare type of blood cancer. Read More
  
  

  Back to Top

• Forum agrees tough measures to combat drug shortages
  
  04 Mar 2010
  The onus will be placed on manufacturers and wholesalers to ensure there is a sufficient supply of medicines to the NHS, health ministers have decided. Read More
  
  

  Back to Top

• AZ to make cuts in UK R&D
  
  03 Mar 2010
  Up to 1,000 workers will lose their jobs at AstraZeneca as the company closes two of its research facilities and ends development in various disease areas. Read More
  
  

  Back to Top

• A global celebration of an amazing organ
  
  03 Mar 2010
  Next week World Kidney Day (Thursday 11th March) will take place to raise awareness of the importance of the kidneys to our overall health. Read More
  
  

  Back to Top

• Big pharma unites against cancers in Asia
  
  02 Mar 2010
  Eli Lilly, Merck (MSD) and Pfizer have joined forces to accelerate research and improve treatment of lung and gastric cancers in Asia. Read More
  
  

  Back to Top

• Alliance completes Cambridge Labs buyout
  
  02 Mar 2010
  Alliance Pharma has completed its acquisition of Cambridge Laboratories for between £14.3 and £16.4 million. Read More
  
  

  Back to Top

• Sanofi-aventis partners with Aviesan
  
  02 Mar 2010
  Sanofi-aventis has signed a research partnership with Aviesan, representing the first alliance of all the players of the academic healthcare research community in France. Read More
  
  

  Back to Top

• Pharma and biotech lead UK R&D investment
  
  01 Mar 2010
  The pharmaceuticals and biotechnology sector dominated UK R&D spending in 2008, the latest R&D scoreboard has revealed. Read More
  
  

  Back to Top

• EMA and FDA simplify orphan drug reporting
  
  01 Mar 2010
  The European Medicines Agency (EMA) and the US Food and Drug Administration (FDA) have agreed to accept a single annual report for orphan drugs for use in both the EU and the US. Read More
  
  

  Back to Top

• Hypertension vaccine project secures investment
  
  01 Mar 2010
  The Austrian Research Promotion Agency (FFG) has donated funds of up to EUR 1.2 million towards the development of a vaccination against hypertension. Read More
  
  

  Back to Top

• NICE reconsiders Nexavar in HCC
  
  26 Feb 2010
  NICE is to convene to decide the fate of Bayer Schering Pharma’s Nexavar (sorafenib) in the treatment of advanced hepatocellular carcinoma (HCC). Read More
  
  

  Back to Top

• Diversication key to pharma success, says Datamonitor
  
  26 Feb 2010
  Top pharmaceutical and biotech companies will face a major decline in sales growth up to 2014, according to a new report. Read More
  
  

  Back to Top

• Marketing award for Schering-Plough
  
  26 Feb 2010
  Schering-Plough has achieved success at this year’s UK Marketing Excellence Awards, receiving the award for best medical supplier. Read More
  
  

  Back to Top

• Kidney fund petitions against ‘callous’ drug appraisals
  
  25 Feb 2010
  The James Whale Fund for Kidney Cancer has launched an online petition at No. 10 Downing Street calling for a review of the current NICE system for appraising cancer drugs. Read More
  
  

  Back to Top

• NICE should retire old drugs, argues BMJ article
  
  25 Feb 2010
  The methods for abandoning old drugs in favour of new ones must be improved, experts on bmj.com have warned. Read More
  
  

  Back to Top

• Basilea and Astellas to co-promote antifungal therapy
  
  25 Feb 2010
  Basilea and Astellas have signed a co-promotion agreement for Basilea’s azole antifungal agent isavuconazole, currently in phase III development for the treatment of invasive fungal infections. Read More
  
  

  Back to Top

• MS charity calls for end to drug access scheme
  
  24 Feb 2010
  The MS Society is campaigning for an end to a scheme that gives multiple sclerosis patients access to drugs that are not recommended by NICE. Read More
  
  

  Back to Top

• UCB partners with the NHS to provide Cimzia to patients
  
  24 Feb 2010
  NICE has finalised its revised Cimzia (certolizumab pegol) guidance, recommending the treatment for some people in England and Wales suffering with rheumatoid arthritis. Read More
  
  

  Back to Top

• Yondelis approved due to cost-sharing scheme
  
  24 Feb 2010
  NICE has overturned its previous guidance on Yondelis (trebactedin) to recommend access to the drug for some cancer patients. Read More
  
  

  Back to Top

• UK’s cancer rate higher than European neighbours
  
  23 Feb 2010
  The UK’s cancer rate is 6% higher than the European average, yet spending on cancer medicines is only 60% that of other advanced western countries. Read More
  
  

  Back to Top

• AZ settles long-running tax dispute
  
  23 Feb 2010
  AstraZeneca has agreed to pay £505 million to HM Revenue & Customs (HMRC) to settle a 15-year tax bill. Read More
  
  

  Back to Top

• First biosimilar epoetin secures EU recommendation
  
  22 Feb 2010
  Retacrit is to become the first biosimilar of epoetin to achieve a subcutaneous licence in renal patients. Read More
  
  

  Back to Top

• Cilag terminates Zeftera deal with Basilea
  
  22 Feb 2010
  Cilag GmbH has decided to terminate its agreement with Basilea Pharmaceutica following an unsuccessful marketing authorisation application for Zeftera. Read More
  
  

  Back to Top

• RNIB launches GP education campaign
  
  22 Feb 2010
  The Royal National Institute of Blind People (RNIB) is to launch an online campaign to improve decision-making about eye health in day-to-day clinical practice. Read More
  
  

  Back to Top

• Roche/Merck test could predict cancer patient responses
  
  19 Feb 2010
  Roche is to collaborate with Merck to develop a test for a gene mutation related to therapeutic resistance in cancer patients. Read More
  
  

  Back to Top

• NHS needs a change of culture, claims Economist report
  
  19 Feb 2010
  Any near-term reforms of the NHS will most likely be gradual, rather than large-scale, and will need to get to the root of how to improve services, argues a new report. Read More
  
  

  Back to Top

• New site provides evidence-based info on psychosis
  
  19 Feb 2010
  A new website has been launched to provide straightforward information, advice and support to relatives and friends of people with psychosis. Read More
  
  

  Back to Top

• Fifth flu vaccine secures recommendation
  
  19 Feb 2010
  The CHMP has recommended a conditional marketing authorisation for a fifth pandemic influenza vaccine – Humenza from Sanofi Pasteur. Read More
  
  

  Back to Top

• AML candidate recommended for orphan status
  
  18 Feb 2010
  The European Medicines Agency (EMA) has recommended orphan drug status for an acute myeloid leukaemia (AML) treatment under development by Swedish biotech company Aprea. Read More
  
  

  Back to Top

• Abbott completes acquisition of Solvay
  
  18 Feb 2010
  Abbott has completed its EUR 4.5 billion acquisition of Belgium-based Solvay Pharmaceuticals. Read More
  
  

  Back to Top

• The British Journal of Clinical Pharmacy secures BOPA publishing agreement
  
  17 Feb 2010
  The British Journal of Clinical Pharmacy (BJ Clin Pharm) has beaten off stiff competition to secure a prestigious publishing agreement with The British Oncology Pharmacy Association (BOPA) — an eminent group of specialist UK pharmacists. Read More
  
  

  Back to Top

• Top pharma campaigns recognised at prestigious awards ceremony
  
  17 Feb 2010
  Product advertising campaigns by Eisai, Schering Plough, Stiefel Laboratories and Wyeth were among the winners at this year’s PM Society Advertising Awards. Read More
  
  

  Back to Top

• NICE requests further data on liraglutide
  
  16 Feb 2010
  NICE has released a preliminary appraisal of liraglutide (Victoza) for the treatment of type 2 diabetes recommending the product under certain conditions. Read More
  
  

  Back to Top

• People need person-centred health services, says CQC
  
  16 Feb 2010
  The Care Quality Commission has applauded overall improvements in health and adult social care services, but said that rising demand and pressure on finances make reform essential. Read More
  
  

  Back to Top

• Medicine reviews improve compliance, says study
  
  16 Feb 2010
  Eighty per cent of patients who took part in the first audit of Medicine Use Reviews (MUR) said an MUR had improved their knowledge of medicines and how to use them. Read More
  
  

  Back to Top

• Report reveals human cost of health inequalities
  
  15 Feb 2010
  Most people in England aren’t living as long as the best off and spend longer in ill-health, according to a new report. Read More
  
  

  Back to Top

• BMA campaigns against NHS commercialisation
  
  12 Feb 2010
  The BMA is urging the public to join its ‘Look After our NHS’ campaign against commercial companies providing NHS care in England. Read More
  
  

  Back to Top

• Pharma shifts focus to ‘healthy outcomes’
  
  11 Feb 2010
  Pharma companies are increasingly looking for innovative ways to collaborate with new players to improve patient services, a new Ernst & Young report has found. Read More
  
  

  Back to Top

• NICE award for Birmingham sight-saving service
  
  11 Feb 2010
  NICE has honoured the ophthalmology team at University Hospitals Birmingham NHS Foundation Trust with an award for its successful implementation of NICE guidance. Read More
  
  

  Back to Top

• More patients to benefit from Procoralan
  
  11 Feb 2010
  The European Medicines Agency (EMEA) has approved a new indication for Servier’s Procoralan (ivabradine). Read More
  
  

  Back to Top

• GSK renews commitment to the world’s poor
  
  10 Feb 2010
  GSK has revealed plans for a new ‘open innovation’ strategy to help deliver new and better medicines for people living in poorer nations. Read More
  
  

  Back to Top

• Seven years of IMS business simulation
  
  10 Feb 2010
  The Pf Awards business simulation will be supported by IMS again this year – representing the seventh year running that the two companies have worked in collaboration. Read More
  
  

  Back to Top

• Industry leaders join forces
  
  10 Feb 2010
  A new website, billed as ‘the voice of UK life sciences’, will launch on 24th February, with a high profile webcast featuring some of the sector’s most respected individuals. Read More
  
  

  Back to Top

• EC approves new treatment for BPH
  
  09 Feb 2010
  Recordati’s Urorec and Silodyx (silodosin) have been approved for launch in Europe for the treatment of benign prostatic hyperplasia (BPH). Read More
  
  

  Back to Top

• Gates Foundation maintains commitment to vaccines
  
  09 Feb 2010
  Medicine in Need (MEND) has received a $3 million grant from the Bill and Melinda Gates Foundation for the development of new malaria vaccine candidates. Read More
  
  

  Back to Top

• Alliance buys Cambridge Labs
  
  09 Feb 2010
  Speciality pharmaceutical company Alliance Pharma has agreed a deal to purchase Cambridge Laboratories in the UK and Ireland for between £14.3m and £16.4m. Read More
  
  

  Back to Top

• NICE rules Afinitor ‘too expensive’
  
  08 Feb 2010
  NICE has ruled that it is unable to recommend Novartis’ everolimus (Afinitor) for the second line treatment of advanced renal cell carcinoma, due to doubts about its ability to extend life. Read More
  
  

  Back to Top

News powered by Pharmaceutical Field (Pf)